Team:TU-Delft/novel approach

From 2013.igem.org

(Difference between revisions)
Line 9: Line 9:
<p>A novel approach for human practice  is essential for attracting the public and help them in understanding the importance of synthetic biology. In this way we made our own in-house Do it yourself (DIY) fluorescent scanner, the <a href="https://2013.igem.org/Team:TU-Delft/Zephyr" target="blank">Zephyr</a>, that is cheaper and affordable than the existing fancy, expensive devices in the market. They make research possible in places where people don't have access to these expensive instruments. These encourages the idea of resource and knowledge sharing.</p>
<p>A novel approach for human practice  is essential for attracting the public and help them in understanding the importance of synthetic biology. In this way we made our own in-house Do it yourself (DIY) fluorescent scanner, the <a href="https://2013.igem.org/Team:TU-Delft/Zephyr" target="blank">Zephyr</a>, that is cheaper and affordable than the existing fancy, expensive devices in the market. They make research possible in places where people don't have access to these expensive instruments. These encourages the idea of resource and knowledge sharing.</p>
<p>We as the team 'Peptidor' were curious and enthusiastic to make our own novel peptides that are not present in nature. We then developed an algorithm that can learn from the various existing antimicrobial peptides (AMP) databases. <a href="https://2013.igem.org/Team:TU-Delft/NovelPeptides" target="blank">This model</a> then suggests some rules by which we manually designed 3 novel peptides. We considered also the effect of these peptides on humans to come up with safe peptides. They were also tested on COS-1 cells to get an idea and prove that they are not toxic to mammals. Thus, safety was always our prime driver to have a clean, healthy and harmless environment.</p>
<p>We as the team 'Peptidor' were curious and enthusiastic to make our own novel peptides that are not present in nature. We then developed an algorithm that can learn from the various existing antimicrobial peptides (AMP) databases. <a href="https://2013.igem.org/Team:TU-Delft/NovelPeptides" target="blank">This model</a> then suggests some rules by which we manually designed 3 novel peptides. We considered also the effect of these peptides on humans to come up with safe peptides. They were also tested on COS-1 cells to get an idea and prove that they are not toxic to mammals. Thus, safety was always our prime driver to have a clean, healthy and harmless environment.</p>
-
 
+
<br><br>
-
<h2 align="center">Implications of project</h2><br>
+
<h2 align="center">Implications of project</h2>
<p>Our project has strong implications on environment , security and safety. The main aim of our project is to have an novel approach to combat MRSA (Methicillin Resistant <i>Staphylococcus aureus</i>). This, clearly suggests that the safety, security and environmental issues that might arise, should to be addressed in an convincing manner.</p>
<p>Our project has strong implications on environment , security and safety. The main aim of our project is to have an novel approach to combat MRSA (Methicillin Resistant <i>Staphylococcus aureus</i>). This, clearly suggests that the safety, security and environmental issues that might arise, should to be addressed in an convincing manner.</p>
<p>The safety and security issues  were considered for choosing some bacterial strains that were in need for our project. We had a detailed discussion with our Bio safety Officer (BVF), as we need to fight  MRSA. She suggested us to use closely related species of BSL-1, as we have only the permit to work with BSL-1 strains. We then used the closely related species <i>S. delphini</i> (DSMZ 20771) which was listed in BSL-1 permit to carry out our minimum inhibitory concentration (MIC) tests.</p>
<p>The safety and security issues  were considered for choosing some bacterial strains that were in need for our project. We had a detailed discussion with our Bio safety Officer (BVF), as we need to fight  MRSA. She suggested us to use closely related species of BSL-1, as we have only the permit to work with BSL-1 strains. We then used the closely related species <i>S. delphini</i> (DSMZ 20771) which was listed in BSL-1 permit to carry out our minimum inhibitory concentration (MIC) tests.</p>

Revision as of 12:57, 4 October 2013


Novel approaches on Human Practice

A novel approach for human practice is essential for attracting the public and help them in understanding the importance of synthetic biology. In this way we made our own in-house Do it yourself (DIY) fluorescent scanner, the Zephyr, that is cheaper and affordable than the existing fancy, expensive devices in the market. They make research possible in places where people don't have access to these expensive instruments. These encourages the idea of resource and knowledge sharing.

We as the team 'Peptidor' were curious and enthusiastic to make our own novel peptides that are not present in nature. We then developed an algorithm that can learn from the various existing antimicrobial peptides (AMP) databases. This model then suggests some rules by which we manually designed 3 novel peptides. We considered also the effect of these peptides on humans to come up with safe peptides. They were also tested on COS-1 cells to get an idea and prove that they are not toxic to mammals. Thus, safety was always our prime driver to have a clean, healthy and harmless environment.



Implications of project

Our project has strong implications on environment , security and safety. The main aim of our project is to have an novel approach to combat MRSA (Methicillin Resistant Staphylococcus aureus). This, clearly suggests that the safety, security and environmental issues that might arise, should to be addressed in an convincing manner.

The safety and security issues were considered for choosing some bacterial strains that were in need for our project. We had a detailed discussion with our Bio safety Officer (BVF), as we need to fight MRSA. She suggested us to use closely related species of BSL-1, as we have only the permit to work with BSL-1 strains. We then used the closely related species S. delphini (DSMZ 20771) which was listed in BSL-1 permit to carry out our minimum inhibitory concentration (MIC) tests.

The lab workers security was considered when we chose the natural peptides. They were chosen not to harm the people working with it and the surroundings. The environmental security was considered to be the most crucial feature of our project. The ultimate application of our project will be a 'Band Aid' having our engineered bacteria. This rises plenty of environmental safety & security concerns on the use and disposal of genetically modified organisms (GMO). To address these concerns, we used a kill switch, BBa_K112808 that was engineered by UC Berkley 2008 iGEM team. The cells undergo autolysis once the required target protein is produced in required quantities.